PeopleBio, Inc. (KOSDAQ:304840)

PeopleBio Statistics

Total Valuation

PeopleBio has a market cap or net worth of KRW 30.93 billion. The enterprise value is 38.90 billion.

Market Cap	30.93B
Enterprise Value	38.90B

Important Dates

The last earnings date was Friday, April 3, 2026.

Earnings Date	Apr 3, 2026
Ex-Dividend Date	n/a

Share Statistics

PeopleBio has 21.17 million shares outstanding. The number of shares has increased by 0.11% in one year.

Current Share Class	21.17M
Shares Outstanding	21.17M
Shares Change (YoY)	+0.11%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.46%
Owned by Institutions (%)	n/a
Float	18.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.85
PB Ratio	1.08
P/TBV Ratio	1.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.48
EV / Sales	13.65
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.21

Financial Position

The company has a current ratio of 0.31, with a Debt / Equity ratio of 0.27.

Current Ratio	0.31
Quick Ratio	0.10
Debt / Equity	0.27
Debt / EBITDA	n/a
Debt / FCF	-1.44
Interest Coverage	-4.52

Financial Efficiency

Return on equity (ROE) is -69.24% and return on invested capital (ROIC) is -28.63%.

Return on Equity (ROE)	-69.24%
Return on Assets (ROA)	-21.28%
Return on Invested Capital (ROIC)	-28.63%
Return on Capital Employed (ROCE)	-39.92%
Weighted Average Cost of Capital (WACC)	8.93%
Revenue Per Employee	61.97M
Profits Per Employee	-341.61M
Employee Count	46
Asset Turnover	0.08
Inventory Turnover	1.47

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.26% in the last 52 weeks. The beta is 0.00, so PeopleBio's price volatility has been lower than the market average.

Beta (5Y)	0.00
52-Week Price Change	-52.26%
50-Day Moving Average	945.74
200-Day Moving Average	1,532.12
Relative Strength Index (RSI)	68.11
Average Volume (20 Days)	1,647,322

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PeopleBio had revenue of KRW 2.85 billion and -15.71 billion in losses. Loss per share was -722.00.

Revenue	2.85B
Gross Profit	-476.51M
Operating Income	-12.20B
Pretax Income	-12.55B
Net Income	-15.71B
EBITDA	-10.45B
EBIT	-12.20B
Loss Per Share	-722.00

Balance Sheet

The company has 80.10 million in cash and 7.76 billion in debt, with a net cash position of -7.68 billion or -362.58 per share.

Cash & Cash Equivalents	80.10M
Total Debt	7.76B
Net Cash	-7.68B
Net Cash Per Share	-362.58
Equity (Book Value)	28.62B
Book Value Per Share	1,302.93
Working Capital	-9.66B

Cash Flow

In the last 12 months, operating cash flow was -5.18 billion and capital expenditures -213.61 million, giving a free cash flow of -5.40 billion.

Operating Cash Flow	-5.18B
Capital Expenditures	-213.61M
Depreciation & Amortization	1.75B
Net Borrowing	-1.35B
Free Cash Flow	-5.40B
FCF Per Share	-254.89

Margins

Gross Margin	-16.72%
Operating Margin	-427.87%
Pretax Margin	-440.11%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PeopleBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.11%
Shareholder Yield	-0.11%
Earnings Yield	-50.80%
FCF Yield	-17.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 23, 2023. It was a forward split with a ratio of 1.2.

Last Split Date	Oct 23, 2023
Split Type	Forward
Split Ratio	1.2

Scores

PeopleBio has an Altman Z-Score of -2.27 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.27
Piotroski F-Score	1